ALOXE3 and neoplasm: As the pathogenic alterations of oncogene YAP culminate in the development of a broad range of human tumor types, including HCC, this finding suggests that YAP-ALOXE3 signaling may be useful as a biomarker to predict HCC cell responsiveness to ferroptosis induction.